A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...

Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...

Kumar's daughter diagnosed with Sickle Cell Anaemia, highlighting challenges faced by tribal communities in Andhra Pradesh.

A Long Island hospital has said that it has successfully eliminated sickle cell disease from Sebastien Beauzile, a 21-year-old from Laurelton, using the groundbreaking Lyfgenia gene therapy. Cohen ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

A Fayetteville teen is making history in North Carolina after undergoing a new gene therapy for sickle cell disease. Aaron Scott was diagnosed with sickle cell at birth. Sickle cell is a genetic ...

Sickle cell disease is a genetic blood disorder characterised by the production of abnormal haemoglobin, which causes red blood cells to become rigid and sickle-shaped. These cells tend to clump ...

Today, CASGEVY is approved for use in patients with sickle cell disease in the United States and multiple countries in Europe and the Middle East. “It’s an amazing gift to have been able to ...

For example, three programmes for dCGTs for sickle cell disease were discontinued by the developing companies in 2023, probably at least in part because they were anticipating the approval of the ...

"Goes from 0 to 1939 in 3 seconds," says the poster from campaign group Everyone Hates Elon as a slump in European Tesla sales also makes headlines. By Lily Ford It appears Elon Musk has enemies ...

Next review: More evidence on exagamglogene autotemcel is being collected. After this, NICE will decide whether to recommend it for use in the NHS and update the guidance. It will be available with ...

A new poster mocking Tesla CEO Elon Musk, who is also an adviser to U.S. President Donald Trump, appeared in a London advertisement space in late February 2025, specifically at a bus stop on the ...